1.A Case of Positive Amniotic AFP, Acetylcholinesterase in a Normal Pregnancy after Undergoing Periodic Targeted Ultrasonographic Evaluation.
Park Hye RI ; Jun Hye SUN ; Dong Hyun CHA ; Sang Won PARK ; Chang Jo CHUNG
Korean Journal of Perinatology 2006;17(4):413-418
Neural tube defects are reported one of the important congenital malformation in the world, with an incidence of 1.4 to 2 per 1000 pregnancies. Maternal serum AFP at the second trimester is used as screening test. But this is associated with numerous causes, including twins, fetal death, misdated pregnancies, cystic hygromas, teratomas, renal abnormalities, esophageal atresia and aberrations in the placenta. If the AFP level was elevated, targeted ultrasonography should be evaluated for confirming the gestational age and fetal viability, fetal number. Then if the ultrasonographic examination is nondiagnostic, or if an NTD is suspected, amniotic fluid AFP should be measured with acetylcholinesterase. But the false positive rate of the AF-AFP is high, and there is 0.3% of the false positive rate in amniotic acetylcholinesterase. This time the women with normal ultrasonographic examination continue the pregnancy after counseling of family history, past history with follow up of ultrasonography. We report a case with elevated second trimester MS-AFP, AF-AFP and positive amniotic acetylcholinesterase, but in which repeated sonographic findings were normal and result in delivery of a healthy baby without anomalies.
Acetylcholinesterase*
;
Amniotic Fluid
;
Counseling
;
Esophageal Atresia
;
Female
;
Fetal Death
;
Fetal Viability
;
Follow-Up Studies
;
Gestational Age
;
Humans
;
Incidence
;
Lymphangioma, Cystic
;
Mass Screening
;
Neural Tube Defects
;
Placenta
;
Pregnancy Trimester, Second
;
Pregnancy*
;
Teratoma
;
Ultrasonography
2.The Association between 10-Year Atherosclerotic Cardiovascular Diseases Risk Score Calculated Using 2013 American College of Cardiology/American Heart Association Guidelines and Serum 25-Hydroxyvitamin D Level among Aged 40–79 Years in Korea: The Sixth .
Mun Hee KIM ; Young Sang KIM ; Hye Jin OH ; Yu Ri KWON ; Hye Won KIM
Korean Journal of Family Medicine 2018;39(3):174-179
BACKGROUND: We examined the relationship between 10-year predicted atherosclerosis cardiovascular disease (ASCVD) risk score and 25-hydroxyvitamin D in Koreans aged 40–79 years. METHODS: A population-based, cross-sectional design was used from data based on the Korea National Health and Nutrition Examination Survey 2014. RESULTS: A total of 1,134 healthy Koreans aged 40–79 years were included. A positive relationship between serum 25-hydroxyvitamin D level and ASCVD score was shown in women (β=0.015) after adjusting for central obesity, physical activity, and supplement intake. The chances of being in the moderate to high risk (risk group, ASCVD score ≥5%) with vitamin D sufficiency (serum 25-hydroxyvitamin D ≥20 ng/mL) was 1.267-fold (95% confidence interval, 1.039–1.595) greater than the chance of being included in the group with vitamin D deficiency (serum 25-hydroxyvitamin D < 20 ng/mL) after adjustments in women. CONCLUSION: Our research indicated a significantly positive association between 25-hydroxyvitamin D and ASCVD score. Further detailed studies to evaluate this correlation are needed.
Atherosclerosis
;
Cardiovascular Diseases*
;
Female
;
Heart*
;
Humans
;
Korea*
;
Motor Activity
;
Nutrition Surveys
;
Obesity, Abdominal
;
Vitamin D
;
Vitamin D Deficiency
3.The Effect of Benzalkonium Chloride on the Paradoxical Bronchoconstriction with Antiasthmatic Respirator Solution.
Young Jin LEE ; Jong Won JUNG ; Un Ki YOON ; Ji Sub OH ; Hye Ri CHA
Pediatric Allergy and Respiratory Disease 1997;7(1):47-56
Recently, some cases of paradoxical bronchoconsthction with the use of nebulized antiasthmatic respirator solutions have been reported. This study was performed to determine whether benzalkonium chloride, contained in several antiasthmatic respirator solutions as a preservative, may cause paradoxical bronchoconstriction. This was accomplished by comparing the FEV(1) change after Ventolin (benzalkonium containing salbutamol) nebulization with the FEV(1) change after Respolin autohaler (benzalkonium free sa1butamol) inhalation within the same patient. This study consisted thirty patients with stable asthma who regularly attend the allergy clinic at Wallace Memorial Baptist Hospital. Patients were excluded from the study if they had respiratory disease or were taking any other medications. The results are as knows: 1) The baseline FEV(1) in the Ventolin group was 73+/-1O(% predicted) and 74+/-10(% predicted) in the Respolin autohaler group, showing no statistical difference in baseline FEV(1) between the two groups. 2) FEV(1) was decreased in 9 subjects(3096) after Ventolin nebu1ization and in 1 subject(3396) after Respolin autohaler inhalation, showing that the incidence of FEV(1) fall was higher in the Vento1in group than in the Respo1in autohaler group(p<0.OO5, one-tailed t-test). 3) Considering the cases with increased FEV(1) after inhalation, FEVl was increased by 9+/-7 (% predicted) in the Vento1in group and 7+/-5(% predicted) in the Respolin autohaIer group, suggesting that bronchodi1ator effects of both medications are similar. 4) Mild coughing occurred in 4 subjects(13396), and mild chest tightness in 1 subject(33%) in the Ventolin group. These symptoms resolved without any treatment. No side effects were reported by subjects in the Respolin autohaler group. In conclusion, these results strongly suggest that the paradoxical bron-choconstriction occurring with nebulized antiasthmatic respirator solutions is due to the ingredient benzalkonium chloride. Therefore we recommend that a benzalkoniulm free salbutamol product should be used for asthmatic patients, or if a product such as Ventolin which contains benza1konium chloride must be used, we recommend that it should be administered cautiously.
Albuterol
;
Asthma
;
Benzalkonium Compounds*
;
Bronchoconstriction*
;
Cough
;
Humans
;
Hypersensitivity
;
Incidence
;
Inhalation
;
Protestantism
;
Thorax
;
Ventilators, Mechanical*
4.Pregnancy outcomes in women aged 35 and older.
Hee Jin PARK ; Sook Hwan LEE ; Dong Hyun CHA ; In Hyun KIM ; Hye Sun JUN ; Kyoung Jin LEE ; Song Ah SONG ; Hey Ri PARK ; Chang Jo CHUNG ; Chung No LEE
Korean Journal of Obstetrics and Gynecology 2006;49(10):2066-2074
OBJECTIVE: To estimate the effect of maternal age on obstetric outcomes, a retrospective analysis was done. METHODS: Twenty six hundred and forty six women who delivered a singleton baby at our hospital from January 1, to December 31, 2004 were enrolled in this study. Subjects were divided into 3 age groups; 1) less than 35 years, 2) 35-39 years, and 3) 40 years and older. Chi-square test was used to assess the effect of age on obstetrics outcome. Then the odds ratio was calculated to represent clinically meaningful risk. RESULTS: A total of 2646 women with complete data were available; 2245 (84.9%) less than 35 years of age; 350 (13.2%) 35-39 years; and 51 (1.9%) 40 years and older. Increasing age was significantly associated with chromosomal abnormalities (OR 3.9and 8.8 for ages 35-39 years and age 40 years and older, respectively), Preterm premature rupture of membranes (OR 1.3 and 3.2) and cesarean delivery (OR 2.0 and 5.5). Patients aged 35-39 years were at increased risk for placenta previa (OR 1.8) and congenital anomaly (OR 2.8) but these were not statistically significant. The rate of the preterm delivery was increased by age (OR 1.3 and 1.9 for ages 35-39 years and age 40 years and older, respectively) but it was not statistically significant (p=0.121). We did not find advanced maternal age to be associated with a statistically increased risk for preeclampsia, congenital anomaly, gestational diabetes, placenta abruption, low birth weight, macrosomia, neonatal morbidity (NICU admission), and perinatal loss. CONCLUSION: In conclusion, although the likelihood of adverse outcomes increases with maternal age, patients and obstetric care providers can be reassured that overall maternal and fetal outcomes are favorable in this patient population.
Chromosome Aberrations
;
Diabetes, Gestational
;
Female
;
Humans
;
Infant, Low Birth Weight
;
Infant, Newborn
;
Maternal Age
;
Membranes
;
Obstetrics
;
Odds Ratio
;
Placenta
;
Placenta Previa
;
Pre-Eclampsia
;
Pregnancy
;
Pregnancy Outcome*
;
Pregnancy*
;
Retrospective Studies
;
Rupture
5.Evaluation of Theophylline Dosing Equation in Korean Infants with Bronchial Asthma.
Deok Cheol CHOI ; Young Hye JUNG ; Un Ki YOUN ; Ji Sub OH ; Yeun Ju PARK ; Charles D SANDS ; Hye Ri CHA
Pediatric Allergy and Respiratory Disease 1997;7(1):82-91
It has been reported that theophylline clearance is lower in Korean infants than in Americans, suggesting that dose requirements for theophylline in Korean infants will be 1ower than those in Americans. Therefore, we reviwed patients charts retrospectively to formulate the new theophylline dosing equation appropiate to Korean infants. We reviewed patient charts of 111 asthmatic infants who received intravenous aminophy1line and oral theophylline in Wa1lace Memorial Baptist Hospital. We set the therapeutic serum concentration at 5-15microgram/ml in Korean infants based on response rate to theophylline therapy, which is supported by National Institute of Health Expert Panel Recommendations. Doses required to achieve a therapeutic serum concentration increased with age. The mean dose among the infants less than 4 months of age was 578+/-154mg/kg/day and increased to 10.12+/-1.78mg/kg/day after 8 months (p<0.0001). The relationship between age and dosage requirements can be expressed by the least squares determination of the linear regression :Dose (mg/kg/day) = 557 + 0.14 X (age in weeks). The coefficient of correlation for this relationship is 0.67(p<0.0001). Half-lives of elimination among the infants studied correspondingly decreased with age. In conclusion, this study showed that the relationship between age and dosage requirements in Korean infants may be different from those in Americans. Therefore, we strongly suggest that it is required to formulate a new theophylline dosing equation appropriate for Korean infants through well-designed prospective studies.
Asthma*
;
Humans
;
Infant*
;
Least-Squares Analysis
;
Linear Models
;
Protestantism
;
Retrospective Studies
;
Theophylline*
6.A Case of Metachronous Development of Esophageal Squamous Cell Carcinoma in the Patient with Esophageal Carcinosarcoma.
Ra Ri CHA ; Woon Tae JUNG ; Hye Won OH ; Hee Jin KIM ; Chang Yoon HA ; Hong Jun KIM ; Tae Hyo KIM ; Gyung Hyuck KO
The Korean Journal of Gastroenterology 2014;64(6):364-369
Esophageal carcinosarcoma is a rare malignant esophageal neoplasm consisting of both carcinomatous and sarcomatous elements, with an incidence of 0.5%. There have been only a few case reports of carcinosarcoma and squamous cell carcinoma coexisting in the esophagus. However, all of these are cases of synchronous or metachronous development of carcinosarcoma after chemoradiotherapy in patients of esophageal squamous cell carcinoma. A 53-year-old man underwent esophagogastroduodenoscopy because of chest pain for several months. Endoscopic examination revealed a huge pedunculated esophageal polypoid mass. Endoscopic submucosal dissection (ESD) was performed and histopathologic examination confirmed spindle cell carcinoma (carcinosarcoma). He refused additional esophagectomy. After 21 months, third follow-up endoscopy showed poorly-demarcated flat, faint discolored lesions at different location from the previous ESD site and endoscopic biopsies confirmed squamous cell carcinoma. To the best of our knowledge, this is the first case of metachronous development of esophageal squamous cell carcinoma in a patient with esophageal carcinosarcoma.
Antineoplastic Agents/therapeutic use
;
Carcinoma, Squamous Cell/*diagnosis/drug therapy/pathology
;
Carcinosarcoma/*diagnosis/drug therapy/pathology
;
Cisplatin/therapeutic use
;
Drug Therapy, Combination
;
Endoscopy, Digestive System
;
Esophageal Neoplasms/*diagnosis/drug therapy/pathology
;
Fluorouracil/therapeutic use
;
Humans
;
Male
;
Middle Aged
;
Positron-Emission Tomography
;
S100 Proteins/metabolism
;
Tomography, X-Ray Computed
;
Tumor Suppressor Protein p53/metabolism
7.The Reliability and Validity of the Korean Version of Behavioral Activation for Depression Scale.
Ji Hye OH ; Na Ri HWANG ; Yun Ji CHA ; Eun Byeol LEE ; Kee Hong CHOI ; Ho Jun SEO
Journal of Korean Neuropsychiatric Association 2017;56(2):89-97
OBJECTIVES: The Behavioral Activation of Depression Scale (BADS) has been reported to be a valid tool for assessing the different behavioral aspects of depression, such as activation, rumination or avoidance, and functional impairment. The aim of this study was to assess the reliability and validity of the Korean version of BADS (K-BADS). METHODS: A sample of 196 outpatients completed the K-BADS and the data were analyzed for internal consistency and factor structures. An additional 51 outpatients re-filled the K-BADS after two weeks for the test-retest reliability. To test for the validity, the Hospital Anxiety and Depression Scale (HADS), Working Alliance Inventory (WAI), Drug Attitude Inventory-10 (DAI-10), and Mindfulness Attention Awareness Scale (MAAS) were administered. RESULTS: Internal consistency of K-BADS was good (Cronbach's alpha=0.843) and principal component factor analysis revealed the four-factor structure. The K-BADS showed a reasonable test-retest reliability (r=0.863, p<0.001). The total score of K-BADS correlated significantly with the total scores of the HADS depression (r=−0.694) and HADS anxiety (r=−0.681). No correlations were found between the K-BADS and the K-WAI (r=0.170) and between the K-BADS and the K-DAI-10 (r=0.311). CONCLUSION: The K-BADS is a reliable and valid instrument for measuring the behavioral activation for depression in Korean patients with depressive symptoms.
Anxiety
;
Depression*
;
Humans
;
Mindfulness
;
Outpatients
;
Reproducibility of Results*
8.A Case of Systemic Lupus Erythematosus Presenting with Acute Pancreatitis.
Yu ri CHOI ; Chan Hee LEE ; Ea Wha KANG ; Min Seob CHA ; Ha na KIM ; Jeong Hye KIE ; Su mi PARK
The Journal of the Korean Rheumatism Association 2010;17(2):211-215
Systemic lupus erythematosus (SLE) is a multisystem inflammatory disorder mediated by autoantibodies and immune complexes that exhibit a range of symptoms. Although thirty-five to forty percent of patients with SLE show signs or symptoms of gastrointestinal involvement, acute pancreatitis is an uncommon complication of SLE, and SLE presenting with acute pancreatitis is extremely rare. We report a case of a 28-year-old female SLE patient who initially presented with acute abdominal pain and elevated pancreatic enzyme levels. The patient was diagnosed clinically with acute pancreatitis and then with SLE after further investigations. Her condition improved after high dose steroid therapy.
Abdominal Pain
;
Adult
;
Antigen-Antibody Complex
;
Autoantibodies
;
Female
;
Humans
;
Lupus Erythematosus, Systemic
;
Pancreatitis
9.A Case of Malignant Perivascular Epithelioid Cell Tumor of the Retroperitoneum with Multiple Metastases.
Hye Won OH ; Tae Hyo KIM ; Ra Ri CHA ; Na Young KIM ; Hyun Jin KIM ; Woon Tae JUNG ; Ok Jae LEE ; Jeong Hee LEE
The Korean Journal of Gastroenterology 2014;64(5):302-306
Perivascular epithelioid cell tumors (PEComas) are unusual mesenchymal neoplasms composed of histologically and immunohistochemically distinct perivascular epithelioid cells (PECs). Although PEComas have the potential to behave in a malignant fashion, malignant PEComas arising from the retroperitoneum are extremely rare. A 68-year-old woman presented with a painful palpable mass in her left upper abdomen. Computed tomography of the abdomen showed a 9 cm sized heterogeneous mass in left para-aortic space and multiple hypervascular nodules in the liver. 18F-fludeoxyglucose-PET/CT showed multifocal hypermetabolic lesions in retroperitoneum, liver, and skeletal bones. Percutaneous needle biopsies were done on the retroperitoneal and hepatic mass. Both specimens were positive for human melanoma black-45 (HMB-45) on histological and immunohistochemical staining which was compatible with PEComas. Herein, we report a rare case of retroperitoneal PEComa with multiple metastases involving liver and bone at initial diagnosis that exhibited aggressive behavior and resulted in a devastating prognosis.
Aged
;
Bone Neoplasms/pathology/radiography/secondary
;
Female
;
Fluorodeoxyglucose F18
;
Humans
;
Liver Neoplasms/pathology/radiography/secondary
;
Perivascular Epithelioid Cell Neoplasms/*diagnosis/pathology
;
Positron-Emission Tomography
;
Tomography, X-Ray Computed
10.Three Cases of Spontaneous Muscle Hematoma in Alcoholic Liver Cirrhosis.
Dong Hoon LEW ; Ja Yoon CHOI ; Ra Ri CHA ; Hye Won OH ; Yun Won JO ; Hyun Ju MIN ; Ok Jae LEE
Korean Journal of Medicine 2014;86(4):472-477
Liver cirrhosis is commonly associated with bleeding complications due to portal hypertension or coagulopathy. Spontaneous muscle hematoma is a rare but potentially lethal complication of liver cirrhosis. Here we report three cases of spontaneous muscle hematoma diagnosed in patients with alcoholic liver cirrhosis. All three patients died due to recurrent bleeding and liver failure although they had undergone repeated transcatheter arterial embolization of the actively bleeding vessels. We reviewed 14 cases of spontaneous muscle hematoma that were associated with liver cirrhosis, including our cases, and found that the mortality rate was 86%, despite early diagnosis and treatment. Cirrhosis-associated spontaneous muscle hematoma occurred more frequently in patients with alcoholic liver cirrhosis, who accounted for -93% of cases. Thus, spontaneous muscle hematoma should be considered a life-threatening complication in patients with alcoholic liver cirrhosis, and abstinence from alcohol may help to prevent the occurrence of this deadly condition.
Alcoholics*
;
Early Diagnosis
;
Fibrosis
;
Hematoma*
;
Hemorrhage
;
Humans
;
Hypertension, Portal
;
Liver Cirrhosis
;
Liver Cirrhosis, Alcoholic*
;
Liver Failure
;
Mortality